Innovating Works

Zytoprotec GmbH

Desconocido
IMPROVE-PD: Identification and Management of Patients at Risk Outcome and Vascular Events in Peritoneal Dialys... ZYTOPROTEC GMBH participó en un H2020: H2020-MSCA-ITN-2018 Peritoneal dialysis (PD) is an underused life saving renal replacement therapy for end-stage kidney disease. Nevertheless, PD patients remai...
2018-09-13 - 2023-06-30 | Financiado
EUTRIPD: European Training and Research in Peritoneal Dialysis ZYTOPROTEC GMBH participó en un FP7: Peritoneal dialysis (PD) and haemodialysis (HD) are life-saving renal replacement therapies for more than 200,000 patients with chronic kidn...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.